SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Agenus (AGEN)
An SI Board Since January 2004
Posts SubjectMarks Bans Symbol
134 22 0 AGEN
Emcee:  Area51 Type:  Unmoderated
AGEN is an interesting company deserving of some discussion\investment consideration in my opinion.

Worthwhile article on the company and to the workings of wall street (piper Jaffrey suspended coverage at 12/01 because it didn't get the secondary offering business)
nyba.org

AGEN is not discussed much on SI, and when it is it is just as likely to be mentioned on the biotech short thread as it is to be mentioned favorably. But some of the shorts concerns (CFO leaving and Jaffrey coverage suspension) were explained in the above article. Short ratio is rather high at about 20% of the float (12/03).

TA aficionados would probably wait for it to pull back (currently 11.77) or clear resistance at 12.40 to 13. A cross of the 50 day sma over the 200 day sma concurrent with a break of resistance might provide a good entry point.
stockcharts.com[l,a]dacanyay[pb50!b200!f][vc60][iUc20!Ll14]&pref=G
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
134Agenus Gets FDA Priority Review of Balstilimab in Cervical Cancer DJ REALTIME Kirk ©-June 17
133New Clinical Responses for AGEN1181 Presented at AACR April 10, 2021 Download PKirk ©-April 11
132Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVIKirk ©-February 4
131Agenus and Betta Pharmaceuticals Enter Into a License Agreement for Balstilimab Kirk ©16/22/2020
130More Good News: ASCO Presentation of Agenus' AGEN1181 by Dr. Steven O'DKirk ©-5/29/2020
129I wasn't aware their cancer therapy would also help with COVID-19, but it maKirk ©-5/13/2020
128It is great to see good news move the stock! First QS-21 Royalty Payment Due toKirk ©-3/10/2020
127Agenus Pipeline Slide agenusbio.com [graphic]Kirk ©-1/14/2020
126News Release Issued: Dec 19, 2019 (7:30am EST) Agenus Commences Combination TriKirk ©-12/19/2019
125News Release Issued: Nov 11, 2019 (8:00am EST) Agenus receives $10M from UroGeKirk ©-11/11/2019
124It is interesting how much the side effects vary. I got my 2nd shot last ThursdKirk ©-11/11/2019
123I took the second Shingles shot on Saturday. My reaction was worse than the firsRarebird-9/30/2019
122Too bad the stock price isn't higher with these results.... but I added receKirk ©-8/9/2019
121Nice hire from a "real company".... Agenus Appoints Don Vidic as ViceKirk ©-7/18/2019
120That sounds similar to my results. I got my first Shingrix shot on July 1st arouKirk ©-7/15/2019
119I feel much better now. I took the Shingrix shot 3pm ( PST) on Saturday. I felt Rarebird-7/15/2019
118Thanks for the post. It served as a reminder to get the first of the two new ShiRarebird-7/13/2019
117What to Know About Shingles and Its Vaccine How to prevent this painful conditiKirk ©-7/11/2019
116Please change the title to the new name, Agenus. agenusbio.com ThanksKirk ©-7/6/2019
115$7.5M worth of good news from #Agenus! Great progress! [tweet]Kirk ©-3/13/2019
114News Release Issued: Mar 8, 2019 (9:00am EST) To view this release online and Kirk ©-3/8/2019
113Agenus to Launch the First Asset-Backed Digital Security Offering in Healthcare Kirk ©-1/29/2019
112Gilead And Agenus Enter into Collaboration to Develop Immuno-Oncology Therapies Kirk ©-12/20/2018
111Looking for breakout at 2.35 for a run up to 2.74. [graphic]Alejandroo Green111/16/2018
110Can you change the name of the board to the current company name, Agenus? ThanksKirk ©-11/7/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):